Chemtura (CHMT) Misses Q3 EPS by 10c

Chemtura (NYSE: CHMT) reported Q3 EPS of $0.20, $0.10 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $558 million versus the consensus estimate of $587.1 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• POET Technologies Inc. (POET) Misses Q2 EPS by 3c
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77